Home › Products › Gynaecology › Nidaglan 8% Gel
Nidaglan 8% Gel
Salt Composition: PROGESTERONE
- Manufacturer: GLAND PHARMA LTD
- Pack Size: 1 TUBE
- Dosage Form: GEL
- Strength: 0.08
- Prescription Required
- Storage: Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F). Keep away from moisture, heat, and light. It should not be frozen. Keep away from children and pets.
₹183.00₹234.35
Inclusive of all taxes
Product Introduction
Nidaglan 8% Gel contains Progesterone as its active ingredient, a naturally occurring female hormone that plays an essential role in regulating the menstrual cycle, supporting pregnancy, and maintaining reproductive health. Progesterone is mainly produced by the ovaries after ovulation, while the placenta produces it during pregnancy. Small amounts of this hormone are also produced by the adrenal glands.
Nidaglan 8% Gel is a synthetic form of Progesterone that works by providing progesterone-like effects in the body. It is commonly prescribed for conditions related to hormonal imbalance, including hormone replacement therapy (HRT) in menopausal women and managing irregular menstrual cycles caused by insufficient progesterone levels.
Before using Nidaglan 8% Gel, patients should inform their healthcare provider about any existing health conditions or allergies. Individuals with a known allergy to Progesterone or any ingredients in the gel should avoid using this medication.
Nidaglan 8% Gel may not be suitable for people with certain medical conditions, including liver disorders, specific hormone-sensitive cancers such as breast or liver cancer, a history of blood clotting problems, or unexplained vaginal bleeding. These conditions may increase the risk of complications or require alternative treatment approaches.
Patients with hormonal or metabolic conditions, such as uncontrolled thyroid disorders or poorly controlled diabetes, may need close medical supervision while using Nidaglan 8% Gel. A healthcare professional may adjust the treatment plan based on individual health needs and response to therapy.
Uses
Hormone replacement therapy: Nidaglan 8% Gel is used along with estrogen to reduce menopausal symptoms. Amenorrhea: A condition in which women donât get their periods for months Reduce the risk of uterine cancer
How it works
The therapeutic effect of Nidaglan 8% Gel is to regulate and support various reproductive processes in the body, including the menstrual cycle, fertility treatments, hormone replacement therapy, and pregnancy maintenance. It helps prepare the uterus for potential pregnancy, maintains the uterine lining, prevents contractions that could lead to miscarriage, and contributes to overall hormonal balance. It can also be used in contraception to inhibit ovulation, thicken cervical mucus, and create an unfavorable environment for sperm, thus preventing pregnancy
How to Use
To use this gel, carefully follow the instructions provided by your healthcare professional and the product labeling. Apply the prescribed amount of gel to a clean, dry area of skin and gently massage it in until fully absorbed. Avoid broken or irritated skin. Allow the gel to dry before covering the area. Wash your hands thoroughly after application. Apply the gel as directed, typically once or twice daily, and rotate the application sites to prevent skin irritation.
Side Effects
Nidaglan 8% Gel cause some side effects like all medications, although not everyone will experience them. Serious: Allergic reaction Swelling Painful urination Vaginal bleeding Depression Memory loss Breast lumps Dark patches on skin Vomiting Blood clots Common: Nausea Bloating Vaginal discharge Mood swings Frequent urination Tiredness
Expert Tips
It is important to inform your healthcare provider about any existing medical conditions, including liver or kidney impairment, epilepsy, or cardiovascular diseases. Some individuals may experience hypersensitivity reactions to Nidaglan 8% Gel, including allergic reactions. Seek immediate medical attention if you develop symptoms such as rash, itching, swelling, or difficulty breathing. It should be used cautiously in individuals with a history of cardiovascular disease, arrhythmias, or those taking other medications that can affect heart rhythm. Pregnant or breastfeeding individuals should seek medical advice before using it. Do not smoke while taking this medication, as this may increase your chances of a blood clot.
References
- Watson Laboratories Inc, US Food and Drug Administration, [Revised on 2007] [Accessed on 12th June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017362s104lbl.pdf
- MP Warren et al., Use of Progesterone in clinical practice, Int J Fertil Womens Med, 1999, 44(2):96-103. [Accessed on 12th June 2023], https://pubmed.ncbi.nlm.nih.gov/10338267/
- Donald G Stein et al, The case for Progesterone, Ann N Y Acad Sci, 2005, 1052:152-69 [Accessed on 12th June 2023], https://pubmed.ncbi.nlm.nih.gov/16024758/
- Edwards M et al., Progestins, NCBI Bookshelf, [Revised on 2020] [Accessed on 12th June 2023], https://www.ncbi.nlm.nih.gov/books/NBK563211/#_NBK563211_pubdet_
- Besins Healthcare (UK) Ltd, Electronic Medicines Compendium (EMC) [Revised on 10 May 2022], [Accessed on 12th June 2023], https://www.medicines.org.uk/emc/product/352/pil#gref
Safety Advice
Pregnancy: safe This medicine is safe for pregnancy if prescribed by your doctor. It does not cause any harm to developing fetus.
Lungs: Consult your doctor If you have pre-existing lung conditions or respiratory issues, it's important to inform your healthcare provider before taking Nidaglan 8% Gel.
Breastfeeding: unsafe Nidaglan 8% Gel may not be recommended while breastfeeding, as it can pass into breast milk and potentially affect the nursing infant.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.